Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1119]

ASCO 2018: Novel treatment strategies in prostate cancer therapeutics

Prof Karim Fizazi and Dr Neal Shore

ASCO 2018: Novel treatment strategies in prostate cancer therapeutics ( Prof Karim Fizazi and Dr Neal Shore )

ASCO 2018: Latest developments in non-metastatic and metastatic castration...

Dr Neal Shore, Dr Simon Chowdhury, Prof Matthew Smith and Prof Boris Hadaschik

ASCO 2018: Latest developments in non-metastatic and metastatic castration-resistant prostate cancer ( Dr Neal Shore, Dr Simon Chowdhury, Prof Matthew Smith and Prof Boris Hadaschik )

Sunitinib with or without surgery for metastatic renal cell carcinoma

Prof Arnaud Mejean - Paris Descartes University, Paris, France

Sunitinib with or without surgery for metastatic renal cell carcinoma ( Prof Arnaud Mejean - Paris Descartes University, Paris, France )

Comment: Kidney surgery may be unneeded in many intermediate-risk patients

Dr Sumanta Pal & Prof Richard Schilsky

Comment: Kidney surgery may be unneeded in many intermediate-risk patients ( Dr Sumanta Pal & Prof Richard Schilsky )

ASCO 2018: Latest in bladder cancer treatments

Prof Thomas Powles & Prof Shahrokh Shariat

ASCO 2018: Latest in bladder cancer treatments ( Prof Thomas Powles & Prof Shahrokh Shariat )

ASCO 2018: Integrating genomic data throughout treatment for prostate cancer

Prof Kurt Miller and Prof Bertrand Tombal

ASCO 2018: Integrating genomic data throughout treatment for prostate cancer ( Prof Kurt Miller and Prof Bertrand Tombal )

Editor’s Choice for May 2018

Prof Gordon McVie - Founding Editor, ecancer

Editor’s Choice for May 2018 ( Prof Gordon McVie - Founding Editor, ecancer )

Expert discussion on metastatic castration resistant prostate cancer

Prof Heather Payne and Dr Luis Martinez-Piñeiro

Expert discussion on metastatic castration resistant prostate cancer ( Prof Heather Payne and Dr Luis Martinez-Piñeiro )

Navigating through the changing treatment landscape of advanced prostate cancer

Prof Heather Payne, Dr Luis Martinez-Piñeiro, Prof Woet Gianotten, Prof Álvaro...

Navigating through the changing treatment landscape of advanced prostate cancer ( Prof Heather Payne, Dr Luis Martinez-Piñeiro, Prof Woet Gianotten, Prof Álvaro Pinto and Prof Anders Bjartell )

Editor's Choice for April 2018

Prof Gordon McVie - Founding Editor, ecancer

Editor's Choice for April 2018 ( Prof Gordon McVie - Founding Editor, ecancer )

Phase I taselisib results and a cell-free DNA assay

Dr José Baselga - Memorial Sloan Kettering Cancer Center, New York, USA

Phase I taselisib results and a cell-free DNA assay ( Dr José Baselga - Memorial Sloan Kettering Cancer Center, New York, USA )

One off PSA prostate screening for men does not save lives

Prof Richard Martin - University of Bristol, Bristol, UK

One off PSA prostate screening for men does not save lives ( Prof Richard Martin - University of Bristol, Bristol, UK )

More from ecancer